Perspective Therapeutics, Inc.

Pharmaceutical company · Seattle, Washington, United States · NYSE: CATX

Perspective Therapeutics, Inc. is a pharmaceutical company headquartered in Seattle, Washington, United States. Its shares trade on NYSE under the ticker CATX. It has reported private securities offerings to the US SEC, most recently $87 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Perspective Therapeutics at a glance

Typepharmaceutical company

HeadquartersSeattle, Washington, United States

Stock listingNYSE: CATX

SEC industryPharmaceutical Preparations

SEC CIK728387

What does Perspective Therapeutics do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $87.4 million sold (2024).

Frequently asked questions about Perspective Therapeutics

Where is Perspective Therapeutics headquartered?

Perspective Therapeutics, Inc. is headquartered in Seattle, Washington, United States.

What does Perspective Therapeutics do?

Perspective Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Perspective Therapeutics a public company?

Yes. Perspective Therapeutics, Inc. trades on NYSE under the ticker CATX.

Similar companies

Omeros CorpSeattle, Washington, United States
Chinook Therapeutics, Inc.Seattle, Washington, United States
Cti Biopharma CorpSeattle, Washington, United States
Aptevo Therapeutics Inc.Seattle, Washington, United States
IPI Legacy Liquidation CoSeattle, Washington, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States
Crinetics Pharmaceuticals, Inc.San Diego, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.